Search results
Is This a Setback for Moderna?
The Motley Fool via AOL· 15 hours agoRSV generally causes cold-like symptoms, but the virus could be severe for certain groups like elderly people or infants. Moderna is seeking approval for...
New Florida law will allow pharmacies to administer a drug that helps prevent the transmission of...
ABC Action News Tampa Bay· 1 day agoFlorida has one of the highest HIV infection rates in the country, and many politicians and medical professionals are trying to curve that rate downward. Recently, Gov. Ron DeSantis signed a ...
Ex-health official sounds alarm on "superbugs" becoming worse than COVID
Newsweek· 1 day agoMore infections could soon become resistant to antibiotics, which will have a more severe impact on...
Skirmish over paper drug info draws on
Politico· 10 hours agoThe agency issued a warning letter to the company last week following an inspection that found that the company made changes to the tests “and these changes reduced the reliability of the tests ...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Laura Kelly must sign HB 2551 into law to help vulnerable Kansans get affordable medicines
The Topeka Capital-Journal via Yahoo News· 3 days agoIn 1992, Congress established the 340B Drug Pricing Program with the objective...
Dynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoDynavax Technologies Corporation (NASDAQ:DVAX) Q1 2024 Earnings Call Transcript May 8, 2024 Dynavax...
Markets News, May 13, 2024: Stocks End Mixed As Investors Await Key Inflation Data; Dow's Winning...
Investopedia· 1 day agoThe delay puts Moderna at a disadvantage versus GSK (GSK) and Pfizer (PFE), whose RSV vaccines have...
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 6 days agoIt provides an alternate treatment pathway for people who might be apprehensive of mRNA technology....
NH firm to market point-of-care COVID-19 antibody test
Hartford Business Journal· 7 days ago-based Nirmidas Biotech Inc. to market its new test, which received emergency use authorization from...